The LZTS1 gene helps control the cell cycle, which is the timed process cells use to grow and divide. In medicine, this gene is important because it helps regulate orderly cell division. If the gene is lost or not working well, cells may multiply in a less controlled way, which can contribute to tumor growth. Changes affecting the LZTS1 gene are mainly studied in cancer tissue rather than as a common inherited cause of disease.
What is a gene?
Genes are stretches of DNA that carry instructions cells use to make molecules or regulate activities in the body. Some genes provide the code for proteins, which do much of the cell’s work. Others are mainly involved in controlling when specific processes happen, where they occur, and how active they are. Taken together, genes affect how the body develops and functions, and they can influence how you react to food, stress, or medications. You can learn more about this topic in the LearnHub.
Overview
LZTS1Gene function
What if the gene works
The LZTS1 gene helps control how cells grow and divide. Its protein supports orderly timing during cell division, which helps tissues replace old cells in a controlled way.
Risk
What if the gene does not work
Variants in the LZTS1 gene can range from milder to more severe changes. Reduced LZTS1 function may weaken control of cell division and the normal signals that help keep cell growth orderly.
Treatment
What does that mean for your treatment
No treatment or management approach linked specifically to the LZTS1 gene is currently established in clinical guidelines. The LZTS1 gene is being studied mainly as a tumor suppressor and possible prognostic biomarker in several cancers, rather than as a guide to drug choice.
Gene function
What if the gene works
Every day, your body replaces worn-out cells in a controlled way. The LZTS1 gene helps control cell division by supporting both timing and structure as a cell splits in two. Its protein is especially important during the later steps of that process.
Inside dividing cells, the LZTS1 gene helps keep key cell cycle signals active at the right time. This supports a steady, well-ordered path through the later stages of cell division.
During cell division, the LZTS1 gene helps steady the spindle, the structure that pulls chromosomes apart. This supports accurate sharing of chromosomes between the two new cells.
What is a variant?
Genetic variants are small differences in a gene’s DNA sequence. These differences are common and are part of normal human diversity, such as variation in appearance, metabolism, or the body’s response to environmental influences. Many variants do not cause any noticeable effects and simply represent natural genetic variation. At times, though, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the LZTS1 gene can alter the protein’s shape, stability, or ability to connect with other proteins that guide cell division. In explaining how variants influence the LZTS1 gene's function, milder variants may partly reduce protein activity, while more disruptive variants can shorten the protein or stop it from being made at all. This often leads to weaker control of the cell cycle, the built in timing system for cell growth and division.
How variants are linked to conditions
At present, research on LZTS1 gene variants and health conditions has not established a broadly confirmed link to one specific inherited condition. Some studies have explored possible connections, but the findings are not consistent enough to treat an LZTS1 gene variant as a clear diagnosis on its own. If you carry a variant in the LZTS1 gene, your doctor or genetic counselor can interpret it alongside your personal and family history.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are common throughout the general population. Most of these variants do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, however, a single well characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the LZTS1 gene. Risk, if present, can also depend on the exact genetic change and other personal and family factors. Anyone with concerns about their own risk should speak with a doctor or genetic counselor.
Inheritance of LZTS1 variants
There is not yet a broadly confirmed Mendelian pattern for how LZTS1 gene variants are inherited in a specific LZTS1 related condition, so the answer to LZTS1 gene inheritance remains cautious and may evolve with research. The LZTS1 gene is located on chromosome 8, which is an autosome. That means you inherit one copy of the LZTS1 gene from your mother and one copy from your father.
What does my LZTS1 result mean for my family?
There is not yet a broadly confirmed inherited pattern tying LZTS1 to one specific genetic condition in families, and research is still developing. If you have a specific LZTS1 result, what it means for relatives depends on the exact change found and why the testing was done.
Genetic information
Genetic testing
How you find out about variants
Testing for LZTS1 gene variants usually uses a blood or saliva sample. A lab reads the DNA in the LZTS1 gene, often as part of a broader panel, and looks for variants. Results may show no variant, a relevant variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
There is not yet a broadly established, LZTS1-specific reason for most people to get genetic testing. Testing decisions are usually based on your personal health history, family history, and whether a doctor or genetic counselor sees a clear reason to look more closely.
A genetic result is only one part of your health story
Genetic test results can provide helpful insight, but how much they explain varies based on the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, also influence how the body functions over time. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help make individual experiences easier to understand.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. This helps explain why the same medication may work well for one person, work less well for another, or cause more side effects in someone else. These differences are common and are one part of the bigger picture alongside age, liver and kidney function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. By looking at links between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medications, genes influence how strongly a drug works or how the body processes it. This information can support more informed, individualized treatment decisions. More about this topic is available in the LearnHub.
Drugs influenced by the LZTS1 gene
When should I seek medical advice?
This gene does not currently have a broadly confirmed role in guiding how medicines are chosen or used. If you have questions about a treatment, side effects, or possible medicine interactions, talk with your doctor or pharmacist.
History
LZTS1 entered the scientific literature in the late 1990s, when researchers studying chromosome 8p22 identified a gene that was often reduced or lost in several cancers. It was first reported under the name FEZ1 before the standard name the LZTS1 gene became more widely used. Early work linked it especially to prostate and other solid tumors, which made it part of a broader effort to map genes involved in tumor development. From these first observations, research expanded steadily. As medical science evolved, so did understanding of this gene, with later studies examining how changes in the LZTS1 gene might contribute to cancer growth and prognosis.